BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38532476)

  • 1. Correction: Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
    Ganci F; Allegretti M; Frascolla C; Spinella F; Rollo F; Sacconi A; De Pascale V; Palcau AC; Manciocco V; Vescovo M; Cotroneo E; Blandino F; Benevolo M; Covello R; Muti P; Strano S; Vidiri A; Fontemaggi G; Pellini R; Blandino G
    Biomark Res; 2024 Mar; 12(1):37. PubMed ID: 38532476
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
    Ganci F; Allegretti M; Frascolla C; Spinella F; Rollo F; Sacconi A; Valentina P; Palcau AC; Manciocco V; Vescovo M; Cotroneo E; Blandino F; Benevolo M; Covello R; Muti P; Strano S; Vidiri A; Fontemaggi G; Pellini R; Blandino G
    Biomark Res; 2024 Mar; 12(1):32. PubMed ID: 38444004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract.
    Pfreundner L; Willner J; Marx A; Hoppe F; Beckmann G; Flentje M
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1287-97. PubMed ID: 10889383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization.
    Pierik AS; Leemans CR; Brakenhoff RH
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
    Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
    Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of molecular diagnostics to predict recurrence of head and neck carcinoma.
    Pena Murillo C; Huang X; Hills A; McGurk M; Lyons A; Jeannon JP; Odell E; Brown A; Lavery K; Barrett W; Sherriff M; Brakenhoff R; Partridge M
    Br J Cancer; 2012 Sep; 107(7):1138-43. PubMed ID: 22918395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.
    Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR
    Oral Oncol; 2023 Oct; 145():106495. PubMed ID: 37478572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
    Ganci F; Sacconi A; Bossel Ben-Moshe N; Manciocco V; Sperduti I; Strigari L; Covello R; Benevolo M; Pescarmona E; Domany E; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
    Ann Oncol; 2013 Dec; 24(12):3082-8. PubMed ID: 24107801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence.
    Kobayashi K; Yoshimoto S; Ando M; Matsumoto F; Murakami N; Omura G; Honma Y; Matsumoto Y; Ikeda A; Sakai A; Eguchi K; Ito A; Ryo E; Yatabe Y; Mori T
    Oral Oncol; 2021 Feb; 113():105091. PubMed ID: 33249291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close distal margin is associated with locoregional rectal cancer recurrence: A multicenter study.
    Varlamos CJ; Sinco B; Van Weiren I; Regenbogen S; Gamboa AC; Silviera M; Abdel-Misih SRZ; Hawkins AT; Balch G; Hendren S
    J Surg Oncol; 2023 Dec; 128(7):1106-1113. PubMed ID: 37458131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
    Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
    Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of secondary tumor-free resection margins in soft tissue on local, regional, and distant recurrence in R0-resected oral squamous cell carcinoma.
    Ooms M; Ponke L; Puladi B; Winnand P; Heitzer M; Katz MS; Hölzle F; Modabber A
    Head Neck; 2022 May; 44(5):1172-1181. PubMed ID: 35188299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutated
    Kampel L; Feldstein S; Tsuriel S; Hannes V; Carmel Neiderman NN; Horowitz G; Warshavsky A; Leider-Trejo L; Hershkovitz D; Muhanna N
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of locoregional recurrence in early stage buccal cancer with pathologically clear surgical margins and negative neck.
    Zaman SU; Aqil S; Sulaiman MA
    Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(4):226-230. PubMed ID: 29551166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer.
    Guo W; Zhang T; Li R; Chen X; Pang J; Bao H; Wu X; Shao Y; Qiu B; Gao S; He J
    Cancer Med; 2023 Jul; 12(14):15026-15036. PubMed ID: 37248810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma.
    Backes C; Bier H; Knopf A
    Oncotarget; 2017 Oct; 8(48):84320-84328. PubMed ID: 29137426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.